The Great Debate Part II: Should Managed Care Rely on Cost Sharing to Manage Big-ticket Biologics? | AJMC

Supplement

Issue:

The Great Debate Part II: Should Managed Care Rely on Cost Sharing to Manage Big-ticket Biologics?

Volume:

12

Number:

6 Suppl

DISCUSSION

INTRODUCTION

The Great Debate Part II

Diana I. Brixner, RPh, PhD; Leslie Fish, RPh, PharmD; and Wayne M. Lednar, MD, PhD

REPORTS

The Case for Cost Sharing for Biologic Therapies

Leslie Fish, RPh, Pharm D

The Case Against Excessive Cost Sharing

Diana I. Brixner, RPh, PhD

Balancing Quality Employee Benefits With Cost Sharing

Wayne M. Lednar, MD, PhD

The Great Debate Part II: Should Managed Care Rely on Cost Sharing to Manage Big-ticket Biologics?

Mark Zitter, MBA

SUPPLEMENT CONTENT

Participating Faculty